Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatase binding	AMPH AKAP5 PPP1R9A NCAM1 SMG5 WNK1 PDLIM4 SLC6A3 MTMR4 PPP1R9B	5.57e-06	264	123	10	GO:0019902
GeneOntologyMolecularFunction	actin binding	XIRP1 AKAP5 PPP1R9A RUSC1 PDLIM4 WASH3P PLEKHG3 MACF1 PPP1R9B MARCKS HDGF MYBPC3	4.09e-05	479	123	12	GO:0003779
GeneOntologyMolecularFunction	protein phosphatase binding	AKAP5 PPP1R9A SMG5 PDLIM4 SLC6A3 MTMR4 PPP1R9B	3.26e-04	210	123	7	GO:0019903
GeneOntologyCellularComponent	growth cone	COPA PPP1R9A NCAM1 NRXN1 BASP1 TRPV2 PPP1R9B MARCKS	9.15e-05	245	121	8	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	COPA PPP1R9A NCAM1 NRXN1 BASP1 TRPV2 PPP1R9B MARCKS	1.14e-04	253	121	8	GO:0030427
GeneOntologyCellularComponent	distal axon	AMPH COPA PPP1R9A NCAM1 SLC6A3 NRXN1 BASP1 TRPV2 PPP1R9B MARCKS	2.22e-04	435	121	10	GO:0150034
Domain	GOLGA6L	GOLGA6L4 GOLGA6L10 GOLGA6L19	5.36e-06	6	122	3	IPR026737
Domain	ARHGEF5_35	ARHGEF5 ARHGEF35	4.23e-05	2	122	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF5 ARHGEF35	4.23e-05	2	122	2	IPR029212
Domain	N-CoR_GPS2_interact	NCOR1 NCOR2	4.23e-05	2	122	2	IPR031557
Domain	GPS2_interact	NCOR1 NCOR2	4.23e-05	2	122	2	PF15784
Domain	GOLGA2L5	GOLGA6L4 GOLGA6L10 GOLGA6L19	2.07e-04	18	122	3	PF15070
Domain	Golgin_A	GOLGA6L4 GOLGA6L10 GOLGA6L19	2.07e-04	18	122	3	IPR024858
Domain	Znf_FYVE_PHD	PHRF1 CHD4 TRIM66 MTMR4 ZFYVE26 KAT6B	4.10e-04	147	122	6	IPR011011
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SCRN1 SMG5 RRBP1 WNK1 PASK NRXN1 ARHGEF10 MACF1 KAT6B	2.45e-07	225	134	9	12168954
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PNPLA2 NOB1 THAP8 SMG5 WNK1 ARHGEF10L ITPR3 MICALL1 NCOR1 NCOR2 SLC38A10 AHNAK CTDP1 ZNF398 ZFYVE26 DLX2 ESPL1 ADAT1	2.70e-07	1105	134	18	35748872
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	CASC3 SFSWAP INCENP PHRF1 RRBP1 LRP1B PDLIM4 NCOR1 CDCA5 MARCKS HDGF	8.54e-07	425	134	11	24999758
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATR SFSWAP COPA PHRF1 CHD4 RRBP1 MICALL1 PASK NCOR1 NCOR2 CTDP1 SAFB2 KAT6B ESPL1	1.90e-06	774	134	14	15302935
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZNF326 ATR SFSWAP COPA PHRF1 CHD4 NCAPH2 CBX4 RRBP1 ITPR3 PWWP2A NCOR1 NCOR2 RBM22 AHNAK SAFB2 PDS5A CDCA5	2.57e-06	1294	134	18	30804502
Pubmed	Functional proteomics mapping of a human signaling pathway.	PAPPA2 PNPLA2 PEG10 CBX4 RRBP1 NCOR1 NCOR2 MTMR4 GMEB1 MACF1 PPP1R9B EPN1	3.33e-06	591	134	12	15231748
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	COPA EGLN1 NOB1 SMG5 RRBP1 MICALL1 RBM22 BASP1 AHNAK MACF1 PPP1R9B ZNF512 ESPL1	4.87e-06	724	134	13	36232890
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	TGIF2LY ZNF180 CHD4 PDLIM4 HOXA1 NCOR2 PPARGC1B ZSCAN18 GMEB1 ZNF398 ZNF747 TGIF2LX DLX2 HDGF	7.91e-06	877	134	14	20211142
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	SPNS1 COPA INCENP PEG10 NUCB1 SCRN1 STARD7 RRBP1 WNK1 NCOR1 MTMR4 BASP1 AHNAK CLPTM1 MACF1 PDS5A MARCKS	1.09e-05	1297	134	17	33545068
Pubmed	Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.	PPP1R9A PPP1R9B	1.47e-05	2	134	2	16600521
Pubmed	CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.	NCOR1 NCOR2	1.47e-05	2	134	2	27733359
Pubmed	Expression of a novel TGIF subclass homeobox gene, Tex1, in the spermatids of mouse testis during spermatogenesis.	TGIF2LY TGIF2LX	1.47e-05	2	134	2	11960710
Pubmed	Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.	NFE2L3 IL6	1.47e-05	2	134	2	36108571
Pubmed	Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice.	PNPLA2 IL6	1.47e-05	2	134	2	25096179
Pubmed	Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25-dihydroxyvitamin D3-responsive genes.	NCOR1 NCOR2	1.47e-05	2	134	2	22944139
Pubmed	Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.	NCOR1 NCOR2	1.47e-05	2	134	2	21131350
Pubmed	In vivo nuclear capture and molecular profiling identifies Gmeb1 as a transcriptional regulator essential for dopamine neuron function.	SLC6A3 GMEB1	1.47e-05	2	134	2	31175277
Pubmed	Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.	NCOR1 NCOR2	1.47e-05	2	134	2	19299558
Pubmed	Unique forms of human and mouse nuclear receptor corepressor SMRT.	NCOR1 NCOR2	1.47e-05	2	134	2	10077563
Pubmed	Nuclear Receptor Corepressors NCOR1 and SMRT Regulate Metabolism via Intestinal Regulation of Carbohydrate Transport.	NCOR1 NCOR2	1.47e-05	2	134	2	39106294
Pubmed	Inhibition of IL-6 trans-signaling in the brain increases sociability in the BTBR mouse model of autism.	ITPR3 IL6	1.47e-05	2	134	2	27460706
Pubmed	Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals.	NCOR1 NCOR2	1.47e-05	2	134	2	31208445
Pubmed	NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.	NCOR1 NCOR2	1.47e-05	2	134	2	29531310
Pubmed	Transient expression of the IL-2 receptor alpha-chain in IL-6-induced myeloid cells is regulated by autocrine production of prostaglandin E2.	IL2RA IL6	1.47e-05	2	134	2	1587308
Pubmed	Association of TGIFLX/Y mRNA expression with prostate cancer.	TGIF2LY TGIF2LX	1.47e-05	2	134	2	18663611
Pubmed	Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.	IL2RA IL6	1.47e-05	2	134	2	24141626
Pubmed	The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses.	IL2RA IL6	1.47e-05	2	134	2	10229817
Pubmed	The human-specific Yp11.2/Xq21.3 homology block encodes a potentially functional testis-specific TGIF-like retroposon.	TGIF2LY TGIF2LX	1.47e-05	2	134	2	12226713
Pubmed	Association of TGIFLX/Y mRNA expression with azoospermia in infertile men.	TGIF2LY TGIF2LX	1.47e-05	2	134	2	18384077
Pubmed	Age-dependent differential regulation of anxiety- and depression-related behaviors by neurabin and spinophilin.	PPP1R9A PPP1R9B	1.47e-05	2	134	2	28700667
Pubmed	Amphiphysin1 inhibits vitronectin-mediated cell adhesion, spreading, and migration in vitro.	AMPH VTN	1.47e-05	2	134	2	12565847
Pubmed	Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.	NCOR1 NCOR2	1.47e-05	2	134	2	26166430
Pubmed	Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?	IL2RA IL6	1.47e-05	2	134	2	19327240
Pubmed	Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A.	PDS5A CDCA5	1.47e-05	2	134	2	35506437
Pubmed	Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study.	IL2RA IL6	1.47e-05	2	134	2	32470973
Pubmed	Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.	PPP1R9A MARCKS	1.47e-05	2	134	2	25757715
Pubmed	Neurabin contributes to hippocampal long-term potentiation and contextual fear memory.	PPP1R9A PPP1R9B	1.47e-05	2	134	2	18183288
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	ZNF326 COPA PPP1R9A NOB1 CHD4 CBX4 RRBP1 LRCH3 ITPR3 BASP1 PLEKHG3 AHNAK SAFB2 PPP1R9B	1.90e-05	949	134	14	36574265
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF326 SALL3 SFSWAP INCENP CHD4 CBX4 RRBP1 NCOR1 NCOR2 AHNAK SAFB2 PDS5A ZNF512 CDCA5	2.02e-05	954	134	14	36373674
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	DDX31 INCENP ARHGEF5 CHD4 CBX4 PWWP2A ZSCAN18 PDS5A ZNF512 HDGF BRWD1	2.52e-05	608	134	11	36089195
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	WBP2 COPA PEG10 NUCB1 CHD4 NCAPH2 SMG5 RRBP1 LRP1B NFE2L3 TRIM66 RBM22 ARHGEF10 HPS4 MACF1 BRWD1	3.73e-05	1285	134	16	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PHRF1 SCRN1 SMG5 RRBP1 ARHGEF10L MICALL1 PASK HPS4 KAT6B ESPL1	4.12e-05	529	134	10	14621295
Pubmed	Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus.	NCOR1 NCOR2	4.41e-05	3	134	2	16030140
Pubmed	Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.	NCOR1 NCOR2	4.41e-05	3	134	2	19098224
Pubmed	The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.	NCOR1 NCOR2	4.41e-05	3	134	2	16373395
Pubmed	Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action.	NCOR1 NCOR2	4.41e-05	3	134	2	31404087
Pubmed	Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation.	NCOR2 IL6	4.41e-05	3	134	2	27239967
Pubmed	Functional consequences of the interactions among the neural cell adhesion molecule NCAM, the receptor tyrosine kinase TrkB, and the inwardly rectifying K+ channel KIR3.3.	NCAM1 KCNJ9	4.41e-05	3	134	2	20610389
Pubmed	Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling.	VTN IL6	4.41e-05	3	134	2	29222114
Pubmed	Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo.	NCOR1 NCOR2	4.41e-05	3	134	2	23292142
Pubmed	Spinophilin/neurabin reciprocally regulate signaling intensity by G protein-coupled receptors.	PPP1R9A PPP1R9B	4.41e-05	3	134	2	17464283
Pubmed	Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19.	IL2RA IL6	4.41e-05	3	134	2	34970527
Pubmed	Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.	NCOR1 NCOR2	4.41e-05	3	134	2	24268577
Pubmed	The motility-associated proteins GAP-43, MARCKS, and CAP-23 share unique targeting and surface activity-inducing properties.	BASP1 MARCKS	4.41e-05	3	134	2	9344590
Pubmed	Oligomerization of ETO is obligatory for corepressor interaction.	NCOR1 NCOR2	4.41e-05	3	134	2	11113190
Pubmed	Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton.	PPP1R9A PPP1R9B	4.41e-05	3	134	2	9653190
Pubmed	GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism.	BASP1 MARCKS	4.41e-05	3	134	2	10871285
Pubmed	EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.	NCOR1 NCOR2	4.41e-05	3	134	2	21518914
Pubmed	Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.	NCOR1 NCOR2	4.41e-05	3	134	2	15802375
Pubmed	SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling.	NCOR1 NCOR2	4.41e-05	3	134	2	36238311
Pubmed	Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.	WNK1 IL6	4.41e-05	3	134	2	32068261
Pubmed	Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.	NCOR1 NCOR2	4.41e-05	3	134	2	18852122
Pubmed	Genetic Study of IL6, GDF5 and PAPPA2 in Association with Developmental Dysplasia of the Hip.	PAPPA2 IL6	4.41e-05	3	134	2	34203285
Pubmed	Regulated clearance of histone deacetylase 3 protects independent formation of nuclear receptor corepressor complexes.	NCOR1 NCOR2	4.41e-05	3	134	2	22337871
Pubmed	Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications.	EGLN1 CHD4	4.41e-05	3	134	2	19624289
Pubmed	Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.	NCOR1 NCOR2	4.41e-05	3	134	2	15016838
Pubmed	Nuclear Receptor CoRepressors, NCOR1 and SMRT, are required for maintaining systemic metabolic homeostasis.	NCOR1 NCOR2	4.41e-05	3	134	2	34390859
Pubmed	RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.	NCOR1 NCOR2	4.41e-05	3	134	2	12011091
Pubmed	A TLR4/TRAF6-dependent signaling pathway mediates NCoR coactivator complex formation for inflammatory gene activation.	NCOR1 PPARGC1B	4.41e-05	3	134	2	38165941
Pubmed	The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.	NCOR1 NCOR2	4.41e-05	3	134	2	10406466
Pubmed	Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation.	NCOR1 NCOR2	4.41e-05	3	134	2	36316474
Pubmed	Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites.	PPP1R9A PPP1R9B	4.41e-05	3	134	2	20305656
Pubmed	The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.	NCOR1 NCOR2	4.41e-05	3	134	2	18052923
Pubmed	The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.	NCOR1 NCOR2	4.41e-05	3	134	2	11997503
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	ZNF326 COPA INCENP CHD4 SAFB2 GMEB1 ZNF512 MARCKS	4.46e-05	330	134	8	33301849
Pubmed	Tagging genes with cassette-exchange sites.	SFSWAP PHRF1 SMG5 NCOR1 NCOR2 SAFB2 MACF1 KAT6B	4.96e-05	335	134	8	15741177
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	SALL3 CHD4 NCOR1 NCOR2	5.33e-05	53	134	4	21532573
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	WNK1 TRIM66 ARHGEF10 ZFYVE26 KAT6B	5.34e-05	104	134	5	9205841
Pubmed	The DNA sequence of human chromosome 7.	AMPH ARHGEF5 PEG10 PPP1R9A SCRN1 HOXA1 NFE2L3 ZNF398 IL6	5.64e-05	441	134	9	12853948
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	ZNF326 COPA ARHGEF5 ARHGEF10L LRCH3 RBM22 ARHGEF10 PLEKHG3 AHNAK PDS5A PPP1R9B CDCA5 MARCKS	5.68e-05	916	134	13	32203420
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NFE2L3 NCOR1 NCOR2	6.08e-05	20	134	3	11877444
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	WBP2 PNPLA2 SPNS1 ATR PEG10 NCAPH2 PASK ADIPOR1 MACF1 PDS5A GNAL EPN1 MARCKS HDGF	6.37e-05	1061	134	14	33845483
Pubmed	Analysis of the DNA sequence and duplication history of human chromosome 15.	GOLGA6L4 GOLGA6L10 WASH3P GOLGA6L19	6.62e-05	56	134	4	16572171
Pubmed	Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex.	NCOR1 NCOR2	8.80e-05	4	134	2	18632669
Pubmed	Molecular cloning of a mouse scavenger receptor with C-type lectin (SRCL)(1), a novel member of the scavenger receptor family.	TGIF2LY TGIF2LX	8.80e-05	4	134	2	11718900
Pubmed	A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.	NCOR1 NCOR2	8.80e-05	4	134	2	19147680
Pubmed	NCoR1 and SMRT play unique roles in thyroid hormone action in vivo.	NCOR1 NCOR2	8.80e-05	4	134	2	25421714
Pubmed	Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK.	NCOR1 NCOR2	8.80e-05	4	134	2	15878880
Pubmed	FBI-1 functions as a novel AR co-repressor in prostate cancer cells.	NCOR1 NCOR2	8.80e-05	4	134	2	20812024
Pubmed	Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton.	PPP1R9A PPP1R9B	8.80e-05	4	134	2	12270929
Pubmed	The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3.	NCOR1 NCOR2	8.80e-05	4	134	2	11509652
Pubmed	The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.	NCOR1 NCOR2	8.80e-05	4	134	2	19211732
Pubmed	Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin.	PPP1R9A PPP1R9B	8.80e-05	4	134	2	29786422
Pubmed	The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits.	PPP1R9A PPP1R9B	8.80e-05	4	134	2	12016225
Pubmed	Pulling rank with RNA: RANKL promotes the association of PGC-1β/RNA complexes with NCoR/HDAC3 to activate gene expression in osteoclasts.	NCOR1 PPARGC1B	8.80e-05	4	134	2	37802020
Pubmed	RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis.	SLC6A3 EPN1	8.80e-05	4	134	2	16885233
Pubmed	A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.	NCOR1 NCOR2	8.80e-05	4	134	2	20543827
Pubmed	GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.	NCOR1 NCOR2	8.80e-05	4	134	2	26712002
Pubmed	Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex.	NCOR1 NCOR2	8.80e-05	4	134	2	26712006
Pubmed	MicroRNAs are mediators of androgen action in prostate and muscle.	NCOR1 NCOR2	8.80e-05	4	134	2	21048966
Interaction	BEND2 interactions	PRR20A BEND2 PRR20C PRR20D PRR20B PRR20E	5.48e-11	12	129	6	int:BEND2
Interaction	ZNF683 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	2.44e-09	10	129	5	int:ZNF683
Interaction	CELF4 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	4.45e-09	11	129	5	int:CELF4
Interaction	SAMD11 interactions	PRR20A NCAPH2 CCNF PRR20C PRR20D PRR20B PRR20E	9.94e-09	43	129	7	int:SAMD11
Interaction	C3orf36 interactions	PPP1R9A PRR20A PRR20C PRR20D PRR20B PRR20E	1.27e-08	26	129	6	int:C3orf36
Interaction	PTTG2 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.90e-08	14	129	5	int:PTTG2
Interaction	MBNL3 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	4.10e-08	16	129	5	int:MBNL3
Interaction	PRR34 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.86e-07	21	129	5	int:PRR34
Interaction	TPRX1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.86e-07	21	129	5	int:TPRX1
Interaction	FAM222B interactions	PRR20A PDLIM4 PRR20C PRR20D PRR20B PRR20E	2.66e-07	42	129	6	int:FAM222B
Interaction	KRTAP19-1 interactions	PRR20A RUSC1 PRR20C PRR20D PRR20B PRR20E	5.30e-07	47	129	6	int:KRTAP19-1
Interaction	LASP1 interactions	THAP8 PRR20A HOXA1 CCNF NCOR2 PRR20C PRR20D PRR20B PRR20E AHNAK PPP1R9B	5.59e-07	247	129	11	int:LASP1
Interaction	ZNF385C interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	2.04e-06	33	129	5	int:ZNF385C
Interaction	CABP2 interactions	PRR20A ITPR3 PRR20C PRR20D PRR20B PRR20E	2.55e-06	61	129	6	int:CABP2
Interaction	TOLLIP interactions	WBP2 INCENP PEG10 PRR20A SCRN1 WNK1 CCNF PRR20C PRR20D PRR20B PRR20E AHNAK	3.34e-06	358	129	12	int:TOLLIP
Interaction	HLX interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	3.68e-06	37	129	5	int:HLX
Interaction	ZCCHC14 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	3.68e-06	37	129	5	int:ZCCHC14
Interaction	TBX3 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E CDCA5	5.27e-06	69	129	6	int:TBX3
Interaction	TBX6 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	6.19e-06	41	129	5	int:TBX6
Interaction	DPYSL5 interactions	TGIF2LY CHD4 CCNF BASP1 PPP1R9B LONRF2	6.23e-06	71	129	6	int:DPYSL5
Interaction	FOXH1 interactions	PRR20A HOXA1 PRR20C PRR20D PRR20B PRR20E PDS5A	6.48e-06	109	129	7	int:FOXH1
Interaction	BICRAL interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	7.87e-06	43	129	5	int:BICRAL
Interaction	RBM42 interactions	ZNF326 SFSWAP CCDC32 NOB1 PRR20A RRBP1 RBM22 PRR20C PRR20D PRR20B PRR20E	9.43e-06	331	129	11	int:RBM42
Interaction	ANKHD1 interactions	NOB1 PRR20A CHD4 CCNF PRR20C PRR20D PRR20B PRR20E NPAS1	1.07e-05	216	129	9	int:ANKHD1
Interaction	SP4 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.10e-05	46	129	5	int:SP4
Interaction	PRR35 interactions	PRR20A RUSC1 PRR20C PRR20D PRR20B PRR20E	1.54e-05	83	129	6	int:PRR35
Interaction	OXER1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.67e-05	50	129	5	int:OXER1
Interaction	DMRT3 interactions	PRR20A RUSC1 PRR20C PRR20D PRR20B PRR20E	2.02e-05	87	129	6	int:DMRT3
Interaction	EIF4ENIF1 interactions	PRR20A SMG5 PASK RBM22 PRR20C PRR20D PRR20B PRR20E HDGF NPAS1	2.38e-05	300	129	10	int:EIF4ENIF1
Interaction	PRR20B interactions	PRR20A BEND2 PRR20C PRR20D PRR20B PRR20E	2.45e-05	90	129	6	int:PRR20B
Interaction	PRR20C interactions	PRR20A BEND2 PRR20C PRR20D PRR20B PRR20E	2.45e-05	90	129	6	int:PRR20C
Interaction	PRR20D interactions	PRR20A BEND2 PRR20C PRR20D PRR20B PRR20E	2.45e-05	90	129	6	int:PRR20D
Interaction	RIPPLY1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	2.68e-05	55	129	5	int:RIPPLY1
Interaction	SNRPB interactions	ZNF326 AKAP5 COPA PRR20A HOXA1 RBM22 PRR20C PRR20D PRR20B PRR20E CTDP1 SAFB2 MACF1	2.81e-05	517	129	13	int:SNRPB
Interaction	ZBTB32 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	3.47e-05	58	129	5	int:ZBTB32
Interaction	FAM9A interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	3.77e-05	59	129	5	int:FAM9A
Interaction	KRTAP19-5 interactions	PRR20A RUSC1 PRR20C PRR20D PRR20B PRR20E	4.21e-05	99	129	6	int:KRTAP19-5
Interaction	ZC3H10 interactions	DDX31 PRR20A PRR20C PRR20D PRR20B PRR20E PPP1R9B ZNF512	4.47e-05	200	129	8	int:ZC3H10
Interaction	PRR20E interactions	PRR20A BEND2 PRR20C PRR20D PRR20B PRR20E	4.72e-05	101	129	6	int:PRR20E
Interaction	TRIM35 interactions	IGFN1 PRR20A PRR20C PRR20D PRR20B PRR20E	5.27e-05	103	129	6	int:TRIM35
Interaction	SIAH2 interactions	PEG10 EGLN1 PRR20A WNK1 NCOR1 PRR20E	5.56e-05	104	129	6	int:SIAH2
Interaction	VEZF1 interactions	PRR20A CHD4 PRR20C PRR20D PRR20B PRR20E	5.87e-05	105	129	6	int:VEZF1
Interaction	C10orf55 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	6.04e-05	65	129	5	int:C10orf55
Interaction	GLIS2 interactions	PRR20A WNK1 PRR20C PRR20D PRR20B PRR20E	6.19e-05	106	129	6	int:GLIS2
Interaction	RBPMS interactions	PRR20A RUSC1 PDLIM4 HOXA1 RBM22 PRR20C PRR20D PRR20B PRR20E TTLL10	6.82e-05	340	129	10	int:RBPMS
Interaction	SH3RF1 interactions	XIRP1 PRR20A PRR20C PRR20D PRR20B PRR20E	6.87e-05	108	129	6	int:SH3RF1
Interaction	SMAP1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	6.99e-05	67	129	5	int:SMAP1
Interaction	PRR20A interactions	PRR20A BEND2 PRR20C PRR20D PRR20B PRR20E	7.23e-05	109	129	6	int:PRR20A
Interaction	PATZ1 interactions	PRR20A CHD4 NCOR1 PRR20C PRR20D PRR20B PRR20E	8.71e-05	163	129	7	int:PATZ1
Interaction	NOTCH3 interactions	PRR20A HOXA1 PRR20C PRR20D PRR20B PRR20E	8.84e-05	113	129	6	int:NOTCH3
Interaction	FOXP3 interactions	ZNF326 ATR PRR20A CHD4 NCAPH2 CBX4 PRR20C PRR20D PRR20B PRR20E ZNF512	1.07e-04	432	129	11	int:FOXP3
Interaction	NMI interactions	TRIM72 THAP8 CHD4 TXLNB PPP1R9B HDGF	1.12e-04	118	129	6	int:NMI
Interaction	THAP1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E TTLL10	1.18e-04	119	129	6	int:THAP1
Interaction	MAGED1 interactions	PRR20A RUSC1 CCNF PRR20C PRR20D PRR20B PRR20E ZFYVE26 NPAS1	1.21e-04	295	129	9	int:MAGED1
Interaction	PHF1 interactions	PRR20A CHD4 PWWP2A PRR20C PRR20D PRR20B PRR20E	1.22e-04	172	129	7	int:PHF1
Interaction	SNRPC interactions	ZNF326 PRR20A NCAPH2 HOXA1 RBM22 PRR20C PRR20D PRR20B PRR20E SAFB2 MACF1	1.25e-04	440	129	11	int:SNRPC
Interaction	PRKACA interactions	PNPLA2 AKAP5 VTN NCAM1 FSCB ITPR3 MICALL1 BASP1 PPP1R9B ESPL1 MARCKS MYBPC3	1.28e-04	519	129	12	int:PRKACA
Interaction	POU2F1 interactions	PRR20A PASK NCOR2 PRR20C PRR20D PRR20B PRR20E	1.36e-04	175	129	7	int:POU2F1
Interaction	ESRP1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.36e-04	77	129	5	int:ESRP1
Interaction	HASPIN interactions	VTN PPP1R9A BASP1 AHNAK PDS5A PPP1R9B	1.41e-04	123	129	6	int:HASPIN
Interaction	PRKAR1B interactions	IGFN1 CCDC32 PPP1R9A NCAM1 RRBP1 WNK1 BASP1 MARCKS	1.50e-04	238	129	8	int:PRKAR1B
Interaction	TOP3B interactions	PNPLA2 PPP1R9A NOB1 THAP8 SMG5 WNK1 ARHGEF10L ITPR3 MICALL1 CCNF NCOR1 NCOR2 SLC38A10 AHNAK CTDP1 SAFB2 ZNF398 PPP1R9B ZFYVE26 DLX2 ESPL1 ADAT1	1.55e-04	1470	129	22	int:TOP3B
Interaction	PITX1 interactions	PRR20A HOXA1 PRR20C PRR20D PRR20B PRR20E	1.68e-04	127	129	6	int:PITX1
Interaction	RBPMS2 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	1.94e-04	83	129	5	int:RBPMS2
Interaction	HIVEP1 interactions	IGFN1 NUCB1 PRR20A PRR20C PRR20D PRR20B PRR20E	1.97e-04	186	129	7	int:HIVEP1
Interaction	CCNK interactions	PRR20A HOXA1 PRR20C PRR20D PRR20B PRR20E	2.07e-04	132	129	6	int:CCNK
Interaction	YPEL3 interactions	PRR20A HOXA1 PRR20C PRR20D PRR20B PRR20E	2.16e-04	133	129	6	int:YPEL3
Interaction	AKT3 interactions	COPA BASP1 PLEKHG3 MARCKS HDGF	2.16e-04	85	129	5	int:AKT3
Interaction	MYO19 interactions	PPP1R9A ITPR3 CCNF BASP1 PLEKHG3 AHNAK PPP1R9B NPAS1	2.22e-04	252	129	8	int:MYO19
Interaction	EWSR1 interactions	CASC3 ZNF326 SFSWAP INCENP ZNF180 PHRF1 CHD4 RRBP1 LRP1B PDLIM4 CCNF NCOR1 SAFB2 CDCA5 MARCKS HDGF	2.23e-04	906	129	16	int:EWSR1
Interaction	CHMP4B interactions	WBP2 VTN COPA INCENP PPP1R9A ITPR3 BASP1 PLEKHG3 AHNAK CTDP1 SAFB2 ZNF747 PPP1R9B GNAL	2.36e-04	727	129	14	int:CHMP4B
Interaction	STAG3L3 interactions	PPP1R9A PLEKHG3	2.42e-04	4	129	2	int:STAG3L3
Interaction	WASH4P interactions	WASH3P WASH4P	2.42e-04	4	129	2	int:WASH4P
Interaction	ATF7IP interactions	PAPPA2 PRR20A RRBP1 PRR20E GMEB1 MACF1	2.64e-04	138	129	6	int:ATF7IP
Interaction	FOXQ1 interactions	ZNF326 COPA CHD4 NCOR2 BASP1 PDS5A	2.96e-04	141	129	6	int:FOXQ1
Interaction	AP2A2 interactions	AMPH CCDC32 CCNF ZBTB46 MTMR4 PPP1R9B EPN1	2.98e-04	199	129	7	int:AP2A2
Interaction	FAM168A interactions	WBP2 PRR20A PRR20C PRR20D PRR20B PRR20E	3.08e-04	142	129	6	int:FAM168A
Interaction	RBM23 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	3.46e-04	94	129	5	int:RBM23
Interaction	ARID5A interactions	PRR20A HOXA1 PRR20C PRR20D PRR20B PRR20E	3.70e-04	147	129	6	int:ARID5A
Interaction	POU6F2 interactions	IGFN1 PRR20A PRR20C PRR20D PRR20B PRR20E	3.84e-04	148	129	6	int:POU6F2
Interaction	SAA1 interactions	PPP1R9A LRCH3 PLEKHG3 SAFB2	3.96e-04	54	129	4	int:SAA1
Interaction	DSN1 interactions	COPA CHD4 CCNF CTDP1 NPAS1	4.00e-04	97	129	5	int:DSN1
Interaction	JPH3 interactions	SFSWAP PPP1R9A PLEKHG3 SAFB2	4.24e-04	55	129	4	int:JPH3
Interaction	CAPZA2 interactions	PPP1R9A LRCH3 ITPR3 MICALL1 CCNF WASH3P PLEKHG3 AHNAK MACF1 PPP1R9B	4.53e-04	430	129	10	int:CAPZA2
Interaction	TCF7L2 interactions	PRR20A CHD4 PRR20C PRR20D PRR20B PRR20E ZNF747 NPAS1	5.05e-04	285	129	8	int:TCF7L2
Interaction	CSNK1A1L interactions	PPP1R9A MTMR4 PLEKHG3 PPP1R9B	5.20e-04	58	129	4	int:CSNK1A1L
Interaction	C1orf94 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	5.27e-04	103	129	5	int:C1orf94
Interaction	GTF2A1 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	5.51e-04	104	129	5	int:GTF2A1
Interaction	RHOXF2 interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	5.51e-04	104	129	5	int:RHOXF2
Interaction	VENTX interactions	PRR20A PRR20C PRR20D PRR20B PRR20E	5.51e-04	104	129	5	int:VENTX
Interaction	TLX3 interactions	PRR20A NCOR1 NCOR2 PRR20C PRR20D PRR20B PRR20E ZNF512	5.79e-04	291	129	8	int:TLX3
Interaction	H3C1 interactions	AKAP5 DDX31 INCENP EGLN1 CHD4 CBX4 RRBP1 NCOR1 BASP1 AHNAK PDS5A KAT6B ZNF512 CDCA5 HDGF	6.54e-04	901	129	15	int:H3C1
Cytoband	13q21.1	PRR20A PRR20C PRR20D PRR20B PRR20E	2.39e-10	13	133	5	13q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr13q21	PRR20A PRR20C PRR20D PRR20B PRR20E	2.44e-05	117	133	5	chr13q21
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF5 ARHGEF10L ARHGEF35 ARHGEF10 PLEKHG3	1.54e-05	66	86	5	722
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	DDX31 PPP1R9A PHRF1 WNK1 ITPR3 NCOR1 PPP1R9B	2.48e-05	181	86	7	694
GeneFamily	PHD finger proteins	PHRF1 CHD4 TRIM66 KAT6B	8.93e-04	90	86	4	88
GeneFamily	Tubulin tyrosine ligase family	TTLL11 TTLL10	1.96e-03	14	86	2	779
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAPPA2 C7 IL2RA	2.53e-03	57	86	3	1179
GeneFamily	Wiskott-Aldrich Syndrome protein family	WASH3P WASH4P	2.57e-03	16	86	2	14
GeneFamily	LIM domain containing	ZNF185 PDLIM4 MICALL1	2.79e-03	59	86	3	1218
GeneFamily	PWWP domain containing	PWWP2A HDGF	4.86e-03	22	86	2	1147
GeneFamily	PDZ domain containing	PPP1R9A PDLIM4 AHNAK PPP1R9B	5.98e-03	152	86	4	1220
GeneFamily	TALE class homeoboxes and pseudogenes	TGIF2LY TGIF2LX	6.75e-03	26	86	2	526
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF326 SALL3 ZNF180 ZBTB46 ZSCAN10 ZSCAN18 ZNF398 ZNF747 ZNF512	7.04e-03	718	86	9	28
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	MTMR4 ZFYVE26	9.51e-03	31	86	2	81
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM72 TRIM71 TRIM66	1.05e-02	95	86	3	59
ToppCell	Bronchial-NucSeq-Stromal-Schwann\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NCAM1 CDH19 PDLIM4 NRXN1 DLX2 MARCKS ADGRL3	1.80e-06	196	130	7	a90c76d9c57a4491b94a321ba541b792ec5d8e83
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NCAM1 CDH19 PDLIM4 NRXN1 DLX2 MARCKS ADGRL3	1.86e-06	197	130	7	4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	NFE2L3 ZBTB46 MTMR4 CLPTM1 GNAL C7	3.84e-06	142	130	6	0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP EGLN1 NFE2L3 PPARGC1B BASP1 ZFYVE26	1.01e-05	168	130	6	9b8a74abb83c64f0b5829dcb4275f722c82b45dc
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP EGLN1 NFE2L3 PPARGC1B BASP1 ZFYVE26	1.01e-05	168	130	6	4b152b8d0f4a66faf664dfacb7914b18d60ce64a
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP EGLN1 NFE2L3 PPARGC1B BASP1 ZFYVE26	1.01e-05	168	130	6	c3169ad8f4130ef18777ed86770bb722ffb5db85
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	NCAM1 CDH19 NRXN1 AHNAK MARCKS ADGRL3	1.01e-05	168	130	6	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATR ZNF180 PDLIM4 ZBTB46 BASP1 IL2RA	1.23e-05	174	130	6	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATR ZNF180 PDLIM4 ZBTB46 BASP1 IL2RA	1.27e-05	175	130	6	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5\|Striatum / BrainAtlas - Mouse McCarroll V32	PASK EDAR DLX2 ESPL1 CDCA5 HDGF	1.64e-05	183	130	6	f20b0d71f857ac35868fd80531050ad8b6091716
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD4 RRBP1 NCOR1 AHNAK MACF1 PDS5A	1.69e-05	184	130	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPH NCAM1 PDLIM4 NRXN1 DLX2 ADGRL3	1.91e-05	188	130	6	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	INCENP NCAM1 CCNF BASP1 ESPL1 CDCA5	2.09e-05	191	130	6	f764cc21fef87ebad765011098f647ae1bdf6158
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PPP1R9A SCRN1 PLEKHG3 AHNAK HPS4 MARCKS	2.15e-05	192	130	6	b016e229300c183e14c0e2bba494bf49c7899112
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PPP1R9A SCRN1 PLEKHG3 AHNAK HPS4 MARCKS	2.15e-05	192	130	6	ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PEG10 PPP1R9A PGM2L1 CDH19 PDLIM4 ADGRL3	2.15e-05	192	130	6	1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHD4 ARHGEF10 BASP1 AHNAK CLPTM1 MARCKS	2.21e-05	193	130	6	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	facs-Brain_Non-Myeloid-Striatum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM234B AKAP5 PPP1R9A NCAM1 SCRN1 GNAL	2.21e-05	193	130	6	d8ccfb780a75bdf9141f41fb29a076958601ebb4
ToppCell	LAM-Epithelial-AirwayEpi\|Epithelial / Condition, Lineage and Cell class	ERICH3 RSPH4A PDLIM4 VWA3B TTLL10 MARCKS	2.21e-05	193	130	6	f2672d2c495ee12c3b7d132452bde581fa5a7856
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERICH3 VTN PDLIM4 ARHGEF10 GNAL MARCKS	2.28e-05	194	130	6	f9fbb043411546d8c9e0321a64165d411f44aeb7
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|Epithelial_cells / Location, Cell class and cell subclass	ERICH3 RSPH4A PDLIM4 VWA3B TTLL10 MARCKS	2.34e-05	195	130	6	a3e2999fdd4c3575add6e28ecfd1d6606a61f992
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R9A RRBP1 PWWP2A MACF1 C7 MARCKS	2.34e-05	195	130	6	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area\|World / Primary Cells by Cluster	PAPPA2 NCAM1 PGM2L1 NRXN1 GNAL KAT6B	2.48e-05	197	130	6	79b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33\|World / Primary Cells by Cluster	PAPPA2 NCAM1 PGM2L1 NRXN1 GNAL KAT6B	2.48e-05	197	130	6	d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell	TCGA-Colorectal-Primary_Tumor\|TCGA-Colorectal / Sample_Type by Project: Shred V9	DDX31 NOB1 CBX4 CCNF NFE2L3 CDCA5	2.63e-05	199	130	6	c7d6a8398f2419b726a0461585d1ee0561654e3b
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	DDX31 NOB1 CBX4 CCNF NFE2L3 CDCA5	2.63e-05	199	130	6	85b3b1ad01368dae4adbc9da7efc148e49992f69
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	AKAP5 RUSC1 NCAM1 PGM2L1 DLX2 NPAS1	2.70e-05	200	130	6	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	RV-16._Neuronal\|World / Chamber and Cluster_Paper	CDH19 NRXN1 AHNAK MARCKS ADGRL3	7.64e-05	149	130	5	3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PPP1R9A NCAM1 CDH19 LRP1B ADGRL3	9.21e-05	155	130	5	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK_CD56bright\|ICU-SEP / Disease, Lineage and Cell Type	AKAP5 PPP1R9A NCAM1 NFE2L3 ZSCAN18	1.01e-04	158	130	5	53a942cdab4a3c6813dbe11368135a24b8de1880
ToppCell	Bronchial-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PPP1R9A NCAM1 CDH19 NRXN1 TTLL11	1.13e-04	162	130	5	afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	AKAP5 ITPR3 DLX2 C7 NPAS1	1.20e-04	164	130	5	4d7b2d0980fb4f47721fa2891151e2bd892ccb91
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATR WDR91 ZBTB46 BASP1 ESPL1	1.23e-04	165	130	5	c39f0479955c4e23921f7a450d3bc251a002200f
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	AKAP5 PEG10 PPP1R9A ZBTB46 IL2RA	1.27e-04	166	130	5	b041010038a570ad929812f35514cb54e4f68f66
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	ARHGEF5 PPP1R9A SCRN1 TRIM71 PDLIM4	1.27e-04	166	130	5	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	ARHGEF5 PPP1R9A SCRN1 TRIM71 PDLIM4	1.31e-04	167	130	5	3ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell	LA-16._Neuronal\|World / Chamber and Cluster_Paper	NCAM1 CDH19 NRXN1 AHNAK ADGRL3	1.34e-04	168	130	5	2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAPPA2 SCRN1 PDLIM4 BASP1 MARCKS	1.38e-04	169	130	5	0f5e737b265ba333275a0cd289dab029a1542075
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	INCENP CCNF TRIM66 ESPL1 CDCA5	1.42e-04	170	130	5	5319f73cff64f2bb67472c7156ee1d0f006c6fc0
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP CCNF BASP1 IL2RA CDCA5	1.42e-04	170	130	5	b04e2f84024baaae9b4ff19bdac8c69afdb92a76
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AMPH CDH19 LRP1B NRXN1 TRPV2	1.42e-04	170	130	5	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AMPH NCAM1 CDH19 ITIH3 ARHGEF10L	1.46e-04	171	130	5	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VTN TRIM71 PPARGC1B NRXN1 MARCKS	1.50e-04	172	130	5	03a0aff6b7971093a4347b5ed12546d78374c56f
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN PPARGC1B PLEKHG3 IL2RA ADGRL3	1.54e-04	173	130	5	d78397e65e997ddb995111a810f0e2a4f67d0765
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN PPARGC1B PLEKHG3 IL2RA ADGRL3	1.54e-04	173	130	5	3c852ffe22f4a5b632463086b08c669310684e80
ToppCell	PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CDH19 PDLIM4 NRXN1 ARHGEF10 DLX2	1.58e-04	174	130	5	0d8e737860120dcd3a6b57992c612595904d585e
ToppCell	wk_20-22-Epithelial-PNS-Late_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CDH19 PDLIM4 NRXN1 ARHGEF10 DLX2	1.67e-04	176	130	5	81924471d8a8c5bd8eedf294c007e25b6cd3e417
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4\|Striatum / BrainAtlas - Mouse McCarroll V32	CCNF DLX2 ESPL1 CDCA5 HDGF	1.67e-04	176	130	5	d70fdc7bc48719776ed1e7c01118385e3a21623f
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	INCENP CCNF TRIM66 ESPL1 CDCA5	1.67e-04	176	130	5	8813c01ea080f373fe3970c5e1ba4c2dca0f7f02
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1\|Striatum / BrainAtlas - Mouse McCarroll V32	CCNF DLX2 ESPL1 CDCA5 HDGF	1.67e-04	176	130	5	a84361308e5e96f3a30246cd29e109c321ee65bf
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	SALL3 INCENP CCNF ESPL1 CDCA5	1.76e-04	178	130	5	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	facs-Marrow-KLS-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB46 MTMR4 AHNAK TRPV2 MARCKS	1.76e-04	178	130	5	6bad4439a1692332f70135ff446a1048fa4c399d
ToppCell	facs-Marrow-KLS-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB46 MTMR4 AHNAK TRPV2 MARCKS	1.76e-04	178	130	5	3f6feb4ed7779cf5684f52939350b41d7718c3c6
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	INCENP CCNF TRIM66 ESPL1 CDCA5	1.81e-04	179	130	5	e67ad7ab04d0c1309296f57c1f53c5ca14c213fe
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 RSPH4A PDLIM4 BASP1 TTLL10	1.85e-04	180	130	5	adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R9A NCAM1 CDH19 DLX2 ADGRL3	1.85e-04	180	130	5	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDH19 PDLIM4 NRXN1 DLX2 MARCKS	1.85e-04	180	130	5	38490017dd590e3fcfa7e88d8d15235d55f90cf1
ToppCell	RA-16._Neuronal\|RA / Chamber and Cluster_Paper	NCAM1 CDH19 NRXN1 AHNAK ADGRL3	1.85e-04	180	130	5	5842febfdabac61ce970254fb0ef17a628f1b8c0
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R9A NCAM1 CDH19 DLX2 ADGRL3	1.85e-04	180	130	5	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R9A NCAM1 CDH19 DLX2 ADGRL3	1.85e-04	180	130	5	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	P15-Endothelial-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	INCENP CCNF PASK CDCA5 HDGF	1.90e-04	181	130	5	0c5bc1660b8fc1e905ab4230202862de5be46ebd
ToppCell	RA-16._Neuronal\|World / Chamber and Cluster_Paper	NCAM1 CDH19 NRXN1 AHNAK ADGRL3	1.90e-04	181	130	5	7d22a43f887e0747f0cb87ba364ff27905ee6eec
ToppCell	5'-Adult-Appendix-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 CDH19 NRXN1 DLX2 ADGRL3	1.90e-04	181	130	5	3aa81ac64d0cc9a74fbfa71e2176740548e7cd06
ToppCell	5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 CDH19 NRXN1 DLX2 ADGRL3	1.90e-04	181	130	5	997ba1be2824b00d684f2163d0114656ed11fa53
ToppCell	P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	INCENP CCNF PASK CDCA5 HDGF	1.90e-04	181	130	5	f83565f09dd971c5cad2704a4a86bca0accd955e
ToppCell	facs-Heart-LV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NRXN1 PLEKHG3 IL2RA ADGRL3	1.90e-04	181	130	5	1db1eb7d330a7e5090994007ae287e11f0a74450
ToppCell	facs-Heart-LV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NRXN1 PLEKHG3 IL2RA ADGRL3	1.90e-04	181	130	5	06174ce9240c9261c0f51a1b0d875335d60722e5
ToppCell	5'-Adult-Appendix-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 CDH19 NRXN1 DLX2 ADGRL3	1.90e-04	181	130	5	e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc
ToppCell	wk_15-18-Epithelial-PNS-intermediate_Schwann\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CDH19 PDLIM4 NRXN1 ARHGEF10 DLX2	2.00e-04	183	130	5	d874aa9a856f79626c8a8371f6196a77b7d662ee
ToppCell	COVID-19_Mild-NK_activated\|COVID-19_Mild / Disease condition and Cell class	ERICH3 NCAM1 MFSD14B AHNAK MACF1	2.00e-04	183	130	5	22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PEG10 SCRN1 BASP1 IL6 MARCKS	2.05e-04	184	130	5	d18e94839a62fca536ae1630c154e5d0aafc44c5
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VTN ITIH3 BASP1 MARCKS ADGRL3	2.05e-04	184	130	5	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	PEG10 GOLGA6L10 NCOR1 ZSCAN18 ADGRL3	2.10e-04	185	130	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	(5)_Pericytes\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	XIRP1 VTN TRPV2 IL2RA IL6	2.16e-04	186	130	5	acbca8cc048d87faf859b3e77bdb38d0a3dad71c
ToppCell	(5)_Pericytes-(50)_Pericytes\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	XIRP1 VTN TRPV2 IL2RA IL6	2.16e-04	186	130	5	67b59defdd1ed3608229cc5e2a3b480d92312afa
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDH19 PDLIM4 NRXN1 DLX2 MARCKS	2.16e-04	186	130	5	6f88b68735d0f7c9904eb8413e6007910d556185
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AKAP5 RSPH4A PPP1R9A WNK1 AHNAK	2.21e-04	187	130	5	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SALL3 INCENP DLX2 CDCA5 MARCKS	2.21e-04	187	130	5	4d12c70c8ed922fbc8f7b139145611203735cab4
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ITIH3 ZBTB46 NRXN1 GNAL C7	2.21e-04	187	130	5	e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SALL3 INCENP DLX2 CDCA5 MARCKS	2.21e-04	187	130	5	e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07
ToppCell	21-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	ERICH3 RSPH4A TXLNB VWA3B TTLL10	2.21e-04	187	130	5	1a2178a195d078d1963947b327c6d0d4f2f48341
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SALL3 INCENP DLX2 CDCA5 MARCKS	2.21e-04	187	130	5	e851ee46a6b4068a7bd7602ee183c0ace50ee4dd
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	PPP1R9A NCAM1 PPARGC1B TXLNB MYBPC3	2.21e-04	187	130	5	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	multiciliated\|World / shred by cell class for bronchial biopsy	ERICH3 RSPH4A BASP1 VWA3B TTLL10	2.27e-04	188	130	5	6833c1f0f265ef5448fa65033550ed7efc2f8d7b
ToppCell	facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 VTN NCAM1 CDH19 NRXN1	2.27e-04	188	130	5	794fc1d9a726945c42f7eac221eed938309b47a9
ToppCell	droplet-Heart-HEART-1m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPH NCAM1 CDH19 PDLIM4 DLX2	2.32e-04	189	130	5	a618a1ddf5097a010c6c2c7341f3a0bd46a29c02
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VTN NRXN1 BASP1 MARCKS ADGRL3	2.32e-04	189	130	5	26cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPH NCAM1 CDH19 PDLIM4 DLX2	2.32e-04	189	130	5	4e61f9cd1c06bddb47ebf98affc0f97770e26e8c
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	NCAM1 PWWP2A AHNAK MACF1 IL6	2.32e-04	189	130	5	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	NCAM1 PWWP2A AHNAK MACF1 IL6	2.32e-04	189	130	5	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VTN NRXN1 BASP1 MARCKS ADGRL3	2.38e-04	190	130	5	2ab604d35456beba71c25511e0f819000e6642d2
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 RSPH4A BASP1 VWA3B TTLL10	2.38e-04	190	130	5	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Epithelial_cells-Ciliated_cells-A\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	ERICH3 RSPH4A VWA3B TTLL10 MARCKS	2.38e-04	190	130	5	549d813a8f23b175875e53347928941f143e236c
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 RSPH4A BASP1 VWA3B TTLL10	2.38e-04	190	130	5	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHD4 RRBP1 AHNAK MACF1 ADGRL3	2.38e-04	190	130	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	ERICH3 RSPH4A VWA3B TTLL10 MARCKS	2.38e-04	190	130	5	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	BASP1 DLX2 KAT6B MARCKS NPAS1	2.38e-04	190	130	5	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	VTN INCENP CCNF ESPL1 CDCA5	2.44e-04	191	130	5	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ERICH3 RSPH4A PDLIM4 TTLL10 MARCKS	2.44e-04	191	130	5	dad675251e129254955eac179c84a641a4864586
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ERICH3 RSPH4A PDLIM4 TTLL10 MARCKS	2.44e-04	191	130	5	6d2cf41ee946137c039ddcc13593fc3f670afbba
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A	DDX31 COPA NCAPH2 RRBP1 PDLIM4 MICALL1 PASK PLEKHG3 SAFB2	1.46e-06	197	125	9	1909_UP
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A	PNPLA2 NCAPH2 SMG5 WNK1 ARHGEF10 CLPTM1 GMEB1 PDS5A KAT6B	1.52e-06	198	125	9	1329_DN
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ARHGEF10L ITPR3 WDR91 NCOR1 SAFB2 GMEB1 MACF1 PDS5A MARCKS	1.52e-06	198	125	9	5467_DN
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A	AKAP5 SMG5 ARHGEF10L NCOR2 ARHGEF10 HPS4 CTDP1 GNAL EPN1	1.59e-06	199	125	9	4064_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	NCAPH2 CBX4 CCNF HPS4 SAFB2 GMEB1 ZNF747 ZFYVE26 BRWD1	1.59e-06	199	125	9	5466_DN
Drug	Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A	FAM234B DDX31 INCENP CBX4 RRBP1 HOXA1 HPS4 CTDP1	1.21e-05	194	125	8	4648_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A	CBX4 RRBP1 WNK1 PASK PLEKHG3 CTDP1 ZNF747 MARCKS	1.25e-05	195	125	8	3503_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A	NCAPH2 SMG5 MICALL1 PLEKHG3 HPS4 CTDP1 SAFB2 MACF1	1.35e-05	197	125	8	2222_DN
Drug	5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA	PNPLA2 SFSWAP RRBP1 ITPR3 WDR91 TRIM66 ZFYVE26 KAT6B	1.40e-05	198	125	8	950_DN
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; PC3; HG-U133A	NCAPH2 PDLIM4 ITPR3 MICALL1 SLC6A3 CCNF TRPV2 SAFB2	1.40e-05	198	125	8	1934_UP
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A	PNPLA2 SMG5 WNK1 CCNF PLEKHG3 SAFB2 ZFYVE26 BRWD1	1.40e-05	198	125	8	1316_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; HL60; HT_HG-U133A	AMPH DDX31 INCENP NCAPH2 NCOR2 DLX2 ADGRL3 NPAS1	1.45e-05	199	125	8	2985_UP
Drug	Artemisinin [63968-64-9]; Up 200; 14.2uM; HL60; HG-U133A	DDX31 ATR SLC38A10 CLPTM1 TRPV2 ZNF747 KAT6B HDGF	1.51e-05	200	125	8	1714_UP
Drug	eicosane	VTN NCAM1 ADIPOR1 HPS4 IL2RA IL6	2.79e-05	107	125	6	CID000008222
Drug	aroclor 1242	PNPLA2 SLC6A3 PPARGC1B	3.43e-05	12	125	3	ctd:C027423
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	NCAPH2 SMG5 HPS4 SAFB2 GMEB1 ZNF747 KAT6B	7.18e-05	184	125	7	4349_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	FAM234B DDX31 PASK PLEKHG3 HPS4 ZFYVE26 KAT6B	7.68e-05	186	125	7	916_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SFSWAP PEG10 CHD4 RRBP1 WNK1 KAT6B MARCKS	7.95e-05	187	125	7	4302_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	SFSWAP NCAPH2 CBX4 NCOR1 HPS4 PDS5A KAT6B	8.49e-05	189	125	7	1168_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A	NCAPH2 SMG5 ARHGEF10L MICALL1 MACF1 PDS5A KAT6B	8.78e-05	190	125	7	1150_DN
Drug	Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A	PNPLA2 TRIM66 PASK PLEKHG3 CTDP1 GMEB1 IL6	8.78e-05	190	125	7	6555_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	FAM234B PASK PLEKHG3 CTDP1 SAFB2 DLX2 KAT6B	9.37e-05	192	125	7	5222_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	SFSWAP COPA NCAM1 NCAPH2 WNK1 TRPV2 KAT6B	9.68e-05	193	125	7	2477_DN
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A	PNPLA2 NUCB1 RRBP1 WNK1 CCNF PLEKHG3 ZNF747	1.00e-04	194	125	7	1307_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A	FAM234B SFSWAP SMG5 RRBP1 CCNF CTDP1 GMEB1	1.00e-04	194	125	7	1405_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A	INCENP SMG5 PASK PLEKHG3 SAFB2 GMEB1 ZNF747	1.00e-04	194	125	7	4572_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	NCAPH2 SMG5 ITPR3 HOXA1 PASK ZNF747 GNAL	1.00e-04	194	125	7	6656_DN
Drug	Ethamivan [304-84-7]; Down 200; 18uM; HL60; HG-U133A	PAPPA2 PNPLA2 MICALL1 PASK NCOR1 AHNAK CLPTM1	1.00e-04	194	125	7	1730_DN
Drug	ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A	WBP2 NUCB1 NCAPH2 SMG5 PASK ZSCAN18 SAFB2	1.00e-04	194	125	7	1179_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	DDX31 SFSWAP NCAPH2 WNK1 MICALL1 WDR91 ZNF747	1.03e-04	195	125	7	1665_DN
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A	NUCB1 CBX4 RRBP1 ITPR3 PLEKHG3 DLX2 BRWD1	1.07e-04	196	125	7	283_UP
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A	RRBP1 SLC38A10 MTMR4 PLEKHG3 HPS4 TRPV2 MYBPC3	1.07e-04	196	125	7	1982_UP
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A	NUCB1 NCAPH2 CBX4 MICALL1 CCNF KAT6B MARCKS	1.07e-04	196	125	7	6247_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A	FAM234B PASK NCOR2 CTDP1 GMEB1 ZNF747 PDS5A	1.07e-04	196	125	7	6323_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	PAPPA2 NCAPH2 MICALL1 CTDP1 GMEB1 ZNF747 KAT6B	1.10e-04	197	125	7	6143_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	PNPLA2 RRBP1 PASK NCOR1 ARHGEF10 SAFB2 BRWD1	1.10e-04	197	125	7	6941_DN
Drug	Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A	PAPPA2 FAM234B NCAPH2 WDR91 ARHGEF10 EPN1 ADGRL3	1.10e-04	197	125	7	4555_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	SFSWAP SMG5 CBX4 CCNF ARHGEF10 PLEKHG3 ZNF747	1.10e-04	197	125	7	2375_DN
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	RRBP1 TRIM66 PASK EDAR MACF1 C7 MYBPC3	1.10e-04	197	125	7	7021_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	PNPLA2 NUCB1 WNK1 MICALL1 SLC38A10 HPS4 ZNF747	1.10e-04	197	125	7	3277_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	NCAPH2 SMG5 WNK1 WDR91 GMEB1 ZNF747 MACF1	1.10e-04	197	125	7	1314_DN
Drug	Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; PC3; HT_HG-U133A	PAPPA2 AMPH AKAP5 WNK1 PASK CTDP1 DLX2	1.10e-04	197	125	7	4014_UP
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	NCAPH2 SMG5 RRBP1 WDR91 ARHGEF10 PLEKHG3 HPS4	1.14e-04	198	125	7	1320_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	NCAPH2 SMG5 RRBP1 ITPR3 PASK HPS4 ZNF747	1.14e-04	198	125	7	6976_UP
Drug	Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HG-U133A	COPA NCAM1 MICALL1 NRXN1 PLEKHG3 SAFB2 GMEB1	1.14e-04	198	125	7	1897_UP
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; HL60; HG-U133A	PNPLA2 DDX31 NCAPH2 CCNF EDAR CTDP1 KAT6B	1.14e-04	198	125	7	1978_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	PAPPA2 AKAP5 DDX31 WNK1 PLEKHG3 AHNAK ADGRL3	1.14e-04	198	125	7	4187_UP
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A	DDX31 NUCB1 WNK1 TRIM66 PASK PLEKHG3 KAT6B	1.14e-04	198	125	7	1291_DN
Drug	Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; MCF7; HT_HG-U133A	PAPPA2 FAM234B NCAPH2 HPS4 SAFB2 ZNF747 ZFYVE26	1.14e-04	198	125	7	1530_DN
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PAPPA2 NCAPH2 CBX4 WDR91 SAFB2 ZNF747 MARCKS	1.14e-04	198	125	7	3313_DN
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; HL60; HT_HG-U133A	NCAPH2 ARHGEF10L LRCH3 CCNF PLEKHG3 GMEB1 KAT6B	1.14e-04	198	125	7	1275_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; PC3; HT_HG-U133A	FAM234B RRBP1 WNK1 MICALL1 NCOR2 ARHGEF10 SAFB2	1.14e-04	198	125	7	4579_DN
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; PC3; HG-U133A	SFSWAP ARHGEF10L MICALL1 ARHGEF10 SAFB2 ZNF747 DLX2	1.14e-04	198	125	7	1924_UP
Drug	Aminophylline [317-34-0]; Up 200; 9.6uM; HL60; HT_HG-U133A	DDX31 PEG10 NCAPH2 RRBP1 ITPR3 GNAL MYBPC3	1.17e-04	199	125	7	3036_UP
Drug	Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A	PAPPA2 COPA RRBP1 MICALL1 CCNF NCOR2 BRWD1	1.17e-04	199	125	7	7524_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A	PNPLA2 SFSWAP RRBP1 ITPR3 MICALL1 CCNF DLX2	1.17e-04	199	125	7	5309_DN
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; HL60; HG-U133A	WBP2 PNPLA2 SFSWAP NUCB1 SMG5 ARHGEF10L KCNJ9	1.17e-04	199	125	7	1403_UP
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A	CDH19 WNK1 NCOR2 PLEKHG3 DLX2 MARCKS BRWD1	1.17e-04	199	125	7	3744_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	PNPLA2 PLEKHG3 CLPTM1 ZSCAN18 SAFB2 ZNF747 KAT6B	1.21e-04	200	125	7	2453_DN
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; PC3; HT_HG-U133A	NCAPH2 CBX4 CCNF TRIM66 PASK PLEKHG3 GMEB1	1.21e-04	200	125	7	5774_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A	FAM234B PNPLA2 NCAPH2 CBX4 PDLIM4 MICALL1 EPN1	1.21e-04	200	125	7	3991_DN
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A	PAPPA2 FAM234B NCAPH2 HOXA1 PASK NCOR2 MYBPC3	1.21e-04	200	125	7	6329_UP
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A	PAPPA2 ZNF185 NCAPH2 RRBP1 EDAR AHNAK DLX2	1.21e-04	200	125	7	2157_DN
Drug	AgBr	SPNS1 PEG10 NUCB1	1.24e-04	18	125	3	CID000066199
Drug	halofenate	NCOR1 NCOR2	1.78e-04	4	125	2	CID000033584
Disease	obsolete aging, cognition	PRR20A PRR20C PRR20D PRR20B PRR20E	3.65e-09	15	125	5	EFO_0003925, GO_0007568
Disease	t-tau:beta-amyloid 1-42 ratio measurement	PRR20A PRR20C PRR20D PRR20B PRR20E	9.15e-06	66	125	5	EFO_0007708
Disease	mosaic loss of chromosome Y measurement	PRR20A PRR20C PRR20D PRR20B PRR20E	2.35e-05	80	125	5	EFO_0007783
Disease	Tinnitus, wellbeing measurement	PRR20A PRR20C PRR20D PRR20B PRR20E	5.65e-05	96	125	5	EFO_0007869, HP_0000360
Disease	TYPE 1 DIABETES MELLITUS	ITPR3 IL6	1.06e-04	4	125	2	222100
Disease	Diabetes mellitus type 1	ITPR3 IL6	1.06e-04	4	125	2	cv:C0011854
Disease	ERO1-like protein alpha measurement	VTN C7	2.64e-04	6	125	2	EFO_0801582
Disease	protocadherin beta-4 measurement	VTN C7	2.64e-04	6	125	2	EFO_0801976
Disease	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement	VTN C7	2.64e-04	6	125	2	EFO_0801372
Disease	Sinusitis	RSPH4A PPP1R9B	3.69e-04	7	125	2	C0037199
Disease	complement C1q and tumor necrosis factor-related protein 9A measurement	VTN C7	6.29e-04	9	125	2	EFO_0803293
Disease	dickkopf-like protein 1 measurement	VTN C7	6.29e-04	9	125	2	EFO_0020324
Disease	cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement	VTN C7	6.29e-04	9	125	2	EFO_0020296
Disease	oxysterols receptor LXR-beta measurement	VTN C7	6.29e-04	9	125	2	EFO_0801865
Disease	apolipoprotein D measurement	VTN C7	6.29e-04	9	125	2	EFO_0020156
Disease	interleukin-34 measurement	VTN C7	6.29e-04	9	125	2	EFO_0020505
Disease	leucine-rich repeat serine/threonine-protein kinase 2 measurement	VTN C7	6.29e-04	9	125	2	EFO_0021876
Disease	marginal zone B-cell lymphoma, multiple sclerosis	ZBTB46 IL2RA	6.29e-04	9	125	2	EFO_1000630, MONDO_0005301
Disease	rectum cancer (is_implicated_in)	CHD4 IL6	6.29e-04	9	125	2	DOID:1993 (is_implicated_in)
Disease	serine/threonine-protein kinase 16 measurement	VTN C7	7.84e-04	10	125	2	EFO_0020724
Disease	interleukin-37 measurement	VTN C7	7.84e-04	10	125	2	EFO_0020506
Disease	Delirium	SLC6A3 IL6	7.84e-04	10	125	2	C0011206
Disease	insulin growth factor-like family member 3 measurement	VTN C7	7.84e-04	10	125	2	EFO_0801700
Disease	Crohn's disease of large bowel	VTN IL2RA IL6	8.66e-04	44	125	3	C0156147
Disease	IIeocolitis	VTN IL2RA IL6	8.66e-04	44	125	3	C0949272
Disease	Diabetes, Autoimmune	ITPR3 IL2RA IL6	8.66e-04	44	125	3	C0205734
Disease	Brittle diabetes	ITPR3 IL2RA IL6	8.66e-04	44	125	3	C0342302
Disease	Diabetes Mellitus, Sudden-Onset	ITPR3 IL2RA IL6	8.66e-04	44	125	3	C4554117
Disease	Diabetes Mellitus, Ketosis-Prone	ITPR3 IL2RA IL6	8.66e-04	44	125	3	C3837958
Disease	Crohn's disease of the ileum	VTN IL2RA IL6	8.66e-04	44	125	3	C0267380
Disease	Regional enteritis	VTN IL2RA IL6	8.66e-04	44	125	3	C0678202
Disease	Autistic Disorder	CHD4 HOXA1 PASK NRXN1 DLX2 IL6	8.82e-04	261	125	6	C0004352
Disease	Diabetes Mellitus, Insulin-Dependent	ITPR3 IL2RA IL6	9.25e-04	45	125	3	C0011854
Disease	tumor necrosis factor receptor superfamily member 11B measurement	VTN C7	9.55e-04	11	125	2	EFO_0020801
Disease	Berylliosis	IL2RA IL6	9.55e-04	11	125	2	C0005138
Disease	Beryllium Disease	IL2RA IL6	9.55e-04	11	125	2	C2350873
Disease	interleukin-10 receptor subunit alpha measurement	VTN C7	9.55e-04	11	125	2	EFO_0021890
Disease	guanylate-binding protein 6 measurement	VTN C7	9.55e-04	11	125	2	EFO_0801662
Disease	glycerol-3-phosphate dehydrogenase 1-like protein measurement	VTN C7	9.55e-04	11	125	2	EFO_0801640
Disease	multiple sclerosis	TRIM71 HOXA1 NCOR2 ZBTB46 ARHGEF10 IL2RA IL6 MARCKS MYBPC3	9.89e-04	594	125	9	MONDO_0005301
Disease	complement component C7 measurement	VTN C7	1.14e-03	12	125	2	EFO_0008093
Disease	Crohn Disease	VTN IL2RA IL6	1.26e-03	50	125	3	C0010346
Disease	kallikrein-12 measurement	VTN C7	1.35e-03	13	125	2	EFO_0008194
Disease	Schizophrenia	NCAM1 CHD4 ITIH3 SLC6A3 NRXN1 HPS4 PPP1R9B GNAL IL2RA IL6 NPAS1	1.36e-03	883	125	11	C0036341
Disease	adverse effect, response to xenobiotic stimulus	LRP1B CTDP1 VWA3B	2.03e-03	59	125	3	EFO_0009658, GO_0009410
Disease	telomere length	PRR20A ZBTB46 PRR20C PRR20D PRR20B PRR20E	2.22e-03	313	125	6	EFO_0004505
Disease	SLAM family member 7 measurement	VTN C7	2.32e-03	17	125	2	EFO_0008287
Disease	Headache	NFE2L3 MACF1 IL6	2.56e-03	64	125	3	HP_0002315
Disease	fatty acid measurement	AMPH SFSWAP INCENP NFE2L3 CLPTM1 MACF1 BRWD1	2.63e-03	436	125	7	EFO_0005110
Disease	phospholipids:total lipids ratio	VTN NFE2L3 CLPTM1 MACF1 MYBPC3	2.86e-03	227	125	5	EFO_0020946
Disease	total blood protein measurement	RRBP1 NCOR2 TXLNB MACF1 IL2RA IL6 HDGF	3.09e-03	449	125	7	EFO_0004536
Disease	venous thromboembolism	PAPPA2 XIRP1 TRIM71 ITPR3 PPARGC1B GNAL BRWD1	3.53e-03	460	125	7	EFO_0004286
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	NCOR2 BRWD1	3.55e-03	21	125	2	EFO_0004616, EFO_0010726, EFO_1000786
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	VTN NFE2L3 NCOR2 CLPTM1 MACF1	3.57e-03	239	125	5	EFO_0008317, EFO_0020945
Disease	lung cancer (is_implicated_in)	ATR CHD4 LRP1B	3.86e-03	74	125	3	DOID:1324 (is_implicated_in)
Disease	Attention Deficit Disorder	SLC6A3 ADGRL3	3.89e-03	22	125	2	C0041671
Disease	Minimal Brain Dysfunction	SLC6A3 ADGRL3	3.89e-03	22	125	2	C1321905
Disease	autism spectrum disorder (implicated_via_orthology)	ITPR3 SLC6A3 NRXN1 ARHGEF10	4.05e-03	152	125	4	DOID:0060041 (implicated_via_orthology)
Disease	susceptibility to strep throat measurement	CCDC32 CDH19 IL2RA	4.17e-03	76	125	3	EFO_0008408

Protein segments in the cluster

Peptide	Gene	Start	Entry
EAEPGAHAPDKEPEL	CTDP1	516	Q9Y5B0
LAAPEAEPAGKVQAP	ERICH3	1216	Q5RHP9
DSLAPGPEPQDEDQK	ARHGEF10	1231	O15013
GPEPQDEDQKDALPS	ARHGEF10	1236	O15013
PRAEEDKPDGQAHEP	ARHGEF10L	1141	Q9HCE6
PVPNPEAESSSKEGE	CDCA5	116	Q96FF9
VEGAPAKDQPSQELP	CDRT15L2	121	A8MXV6
PSFPKEGSADVEPNQ	ARHGEF5	76	Q12774
TQTEPPPAKCGDAED	ADGRL3	1376	Q9HAR2
PSFPKEGSADVEPNQ	ARHGEF35	76	A5YM69
GPKVDVNAPDVQAPD	AHNAK	2491	Q09666
SSPANNEPEKEDLEP	DLX2	126	Q07687
QSPADKACDTPDKPV	ADAT1	41	Q9BUB4
IGAEPKETTEDAAPP	AMPH	561	P49418
PTDPDDPLADQNIKD	RBM22	186	Q9NW64
VDTCPIKPEAPGEDE	PYY3	26	Q5JQD4
QKTDEKVDESGPPAP	PDS5A	1251	Q29RF7
CVVEPAAGDLDNPPK	ITPR3	36	Q14573
ADKEQNGCLPPPESE	KCNJ9	376	Q92806
PPTEGKQAAPAENEA	NPAS1	441	Q99742
NSEPKELAGDPEAVP	KAT6B	1486	Q8WYB5
TAAAPPVEEGEEQKP	NCOR2	831	Q9Y618
PARPHGPEDKDQAVE	PNPLA2	266	Q96AD5
KPFASCEDSEAPVPA	PASK	541	Q96RG2
PKAEEEQTCPVPQEE	ADIPOR1	46	Q96A54
EEAEVRQPKGPDPDS	LRCH3	386	Q96II8
PPQETEKGHSACEPE	NOB1	136	Q9ULX3
PDNPNGCKSLSDEEP	LRP1B	3001	Q9NZR2
DAVVATADEPPPKNG	TRIM71	121	Q2Q1W2
PAPDPEAEDTEGKAV	GMEB1	526	Q9Y692
VGSEQKEPPEEAEPV	INCENP	371	Q9NQS7
EAKTDQADGPREPPQ	INCENP	431	Q9NQS7
AEGALEEAPAKVEPP	FSCB	401	Q5H9T9
SDEEPAPDKQGSPEL	EDAR	286	Q9UNE0
PTSPDEACPDGRKEN	HPS4	311	Q9NQG7
PELEQESKPGDPDAT	BEND2	781	Q8NDZ0
TPKESEPQAAAEPAE	BASP1	36	P80723
AEEPKPVEAPAANSD	BASP1	206	P80723
PDFSTVKCPNPEEGE	PGM2L1	296	Q6PCE3
KSPLGEAPEPDSDAE	FAM234B	51	A2RU67
EKAPAEPTAQVPDAG	NFE2L3	171	Q9Y4A8
KSCVEEPEPEPEAAE	HDGF	106	P51858
EECPEDLPEKFDGNP	PEG10	76	Q86TG7
AAEKAEAPSSPDVAP	PHRF1	1351	Q9P1Y6
EAPSSPDVAPAGKED	PHRF1	1356	Q9P1Y6
CPDDPQPAKDQLATV	MACF1	396	O94854
EADGPKASPEARPQI	MICALL1	266	Q8N3F8
EPPAGPSKVEQLQDE	GOLGA6L3	151	A6NEY3
EPPAGPSKVEQLQDE	GOLGA6L4	151	A6NEF3
EPPAGPSKVEQLQDE	GOLGA6L10	151	A6NI86
EPPAGPSKVEQLQDE	GOLGA6L19	151	H0YKK7
DVEDAPDLNAPGKIP	LONRF2	406	Q1L5Z9
SPATPPGNDEKAEES	HOXA1	296	P49639
PVDSGEVKLDDEPPN	NRXN1	196	Q9ULB1
KDKAVQEVCPPPAGD	DDX31	456	Q9H8H2
QEVCPPPAGDKLDSF	DDX31	461	Q9H8H2
TDDVPVPAPAGDQKE	NUCB1	426	Q02818
EETKGPAPDPSAQDE	MTMR4	726	Q9NYA4
SVEADGPAQPAQPAK	PRR20D	36	P86480
TVPEDATPDAGEDPK	GNAL	306	P38405
SVEADGPAQPAQPAK	PRR20A	36	P86496
SVEADGPAQPAQPAK	PRR20B	36	P86481
KPDTEGNAVSLVPPD	PAPPA2	96	Q9BXP8
AEDTAAPAEESKPAP	CBY2	271	Q8NA61
ELCFPENETPPEGKN	ATR	1981	Q13535
EEVCPTESKPEVPQA	ESPL1	1366	Q14674
LGSPEKEEAASEPPA	CASC3	371	O15234
KEEAASEPPAAAPDA	CASC3	376	O15234
EEACPEDKGPQDPQA	CCNF	656	P41002
IPKDADSQNPDAPEG	COPA	396	P53621
CPSPPALKDGFVQDE	C7	571	P10643
EKPPAEAQDEPAESL	CBX4	516	O00257
KCPQEAGASDQPEPT	AKAP5	61	P24588
EVPSEQYACEGKPPD	BRWD1	1986	Q9NSI6
SAVAAEAEPGKEEPP	EGLN1	136	Q9GZT9
PEAGASPVEKEAPAE	MARCKS	96	P29966
EAAVAPEKPPASDET	MARCKS	241	P29966
EEKPQASPEGRPESE	IL2RA	196	P01589
PESQVEKPVAEDEPA	CCDC32	161	Q9BV29
KEEADQPPSCGPEDD	EPN1	196	Q9Y6I3
EIPEGCSTPDFEQKP	IGFN1	21	Q86VF2
PVPPAEDGIKIEENS	CHD4	1556	Q14839
PPNVSVFEPKASAED	SALL3	401	Q9BXA9
PEADGQPAVQPAKED	SLC38A10	581	Q9HBR0
EKLEEANTDPCAPPF	CDH19	701	Q9H159
PPELEEKAASEPEAG	MFSD14C	6	Q5VZR4
PPELEEKAASEPEAG	MFSD14B	6	Q5SR56
PPGEDSKDVAAPHRQ	IL6	31	P05231
VSPAAGEEAPAAKEP	RUSC1	431	Q9BVN2
EPESSEPLEAKQGPE	RSPH4A	36	Q5TD94
VKCEANGAVPDDPSP	PWWP2A	231	Q96N64
NPLPEAEAGKIEESP	SFSWAP	696	Q12872
LAQDPAPATVDAKPE	THAP8	251	Q8NA92
DGPAETQSPVEKDSP	TGIF2LX	6	Q8IUE1
DGPAETQSPVEKDSP	TGIF2LY	6	Q8IUE0
PCVNGDVDKPSEPAS	SMG5	606	Q9UPR3
NDPSVAENGAPEPKT	TCP11X1	11	B4DZS4
CQPKEEGSRDPADPS	PLEKHG3	1186	A1L390
ADKPGEDAEATPVSP	ITIH3	616	Q06033
EEGSVCDPPPATKAD	NCOR1	806	O75376
CDPPPATKADSVDVE	NCOR1	811	O75376
EPAEPVAAEPKQSGS	PDLIM4	196	P50479
SVEADGPAQPAQPAK	PRR20C	36	P86479
EGFACPEKETPSLNP	SKIDA1	736	Q1XH10
SVEADGPAQPAQPAK	PRR20E	36	P86478
EDKEPGEDCPSPQPA	PPARGC1B	246	Q86YN6
LVPKTQSPCFGDDDP	SCRN1	316	Q12765
QSPCFGDDDPAKKEP	SCRN1	321	Q12765
SASEPQEAPPKPAED	CLPTM1	651	O96005
EGAPEPASCVKETPD	NCAPH2	301	Q6IBW4
TEPEKGPVEAKPECQ	NCAM1	816	P13591
KPECQETETKPAPAE	NCAM1	826	P13591
KVLAPAPAQPSAAEE	TTLL11	151	Q8NHH1
QDQKPPCAPESKAEA	ZSCAN10	401	Q96SZ4
ESEEEDESCRPPPGK	nan	66	Q6ZSR9
DVAQSPEAPKQEAPA	RRBP1	611	Q9P2E9
KTPDCAPAEAPAQAQ	SPEM3	196	A0A1B0GUW6
TGNPKSEEPEVPDQE	SPNS1	31	Q9H2V7
EEEPQVGAPPESKES	ZNF398	236	Q8TD17
PVCVSTKPEPEDDAE	WASH4P	156	A8MWX3
QDPEVAKCPTEADPD	ZNF747	101	Q9BV97
APAKEPNAVGPKEVE	SLC6A3	16	Q01959
NPVLASPPKEDEDGA	TRPV2	736	Q9Y5S1
PVCVSTKPEPEDDAE	WASH3P	141	C4AMC7
FDFDACNEVPPAPKE	SAFB2	356	Q14151
VECSEQKAPPAGEDP	TRIM72	311	Q6ZMU5
QDEKPPEPPKACAQD	ZNF180	31	Q9UJW8
KAPDPQDPQDAESDS	ZSCAN18	331	Q8TBC5
PPEPKAQTEGNEDSE	STARD7	121	Q9NQZ5
AESDPANCEPPSEKA	TEX28	136	O15482
QESADAALKEPEQPP	TXLNB	531	Q8N3L3
FGCKDPTPPEAVQNE	VWA3B	661	Q502W6
PEVDSDTQPKAPGID	WNK1	1636	Q9H4A3
KGPPAPIENEDFCAV	TRIM66	961	O15016
CAEKKPEASGPEAEP	WDR91	351	A4D1P6
PSPGTAKEEREEPEN	TTLL10	656	Q6ZVT0
LKPEEEAPAPEVGAS	VTN	116	P04004
VSASCKEPEQEPVPA	ZNF512	536	Q96ME7
AKDPQQEPDAVDAPV	ZFYVE26	471	Q68DK2
CNKDVPEEPSEKPEA	ZFYVE26	1871	Q68DK2
EEAGAEAPPKEEVVP	XIRP1	361	Q702N8
VVEEDGPSEKSQDPP	ZNF185	221	O15231
QEPKADGPDDVSSQP	ZBTB46	201	Q86UZ6
PDVPSTPAAEAKAAE	WBP2	211	Q969T9
TAKEEPADFPVEQPE	ZNF326	566	Q5BKZ1
VPDAPAAPKISNVGE	MYBPC3	771	Q14896
QTPDSIDKDGPEEPC	PPP1R9A	311	Q9ULJ8
ATAASPAPEEPKAQA	PPP1R9B	336	Q96SB3